All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 500 | older 500) (20 | 50 | 100 | 250 | 500)- 13:38, 3 January 2023 Jwarner talk contribs created page Category:EMA withdrawn in 2018 (Created page with "Category:Discontinued drugs")
- 13:34, 3 January 2023 Jwarner talk contribs created page Category:EMA withdrawn in 2020 (Created page with "Category:Discontinued drugs")
- 12:10, 3 January 2023 Jwarner talk contribs created page Category:EMA withdrawn in 2021 (Created page with "Category:Discontinued drugs")
- 14:19, 2 January 2023 Jwarner talk contribs created page Pertuzumab & Trastuzumab hyaluronidase (Phesgo) (Created page with "==General information== A combination of pertuzumab and trastuzumab, to be given by subcutaneous injection ==History of changes in FDA indication== *6/29/2020: Initial FDA ap...")
- 12:37, 31 December 2022 Jwarner talk contribs moved page Ropeginterferon alfa-2b (AOP2014) to Ropeginterferon alfa-2b (Besremi) (EMA approval)
- 12:31, 31 December 2022 Jwarner talk contribs moved page Lipefilgrastim (XM22) to Lipefilgrastim (Lonquex) (EMA approval)
- 02:38, 31 December 2022 Jwarner talk contribs created page Category:EMA approved in 2007 (Created page with "Category:EMA approved in the 2000s")
- 02:34, 31 December 2022 Jwarner talk contribs created page Category:EMA withdrawn in 2019 (Created page with "Category:Discontinued drugs")
- 02:19, 31 December 2022 Jwarner talk contribs created page Category:EMA approved in 2022 (Created page with "Category:EMA approved in the 2020s")
- 12:53, 30 December 2022 Jwarner talk contribs created page Pyrotinib (Irene) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrotinib NCI Drug Dictionary]: An orally bioavailable, dual...")
- 01:57, 28 December 2022 Jwarner talk contribs created page Category:Paroxysmal nocturnal hemoglobinuria medications (investigational) (Created page with "Category:Paroxysmal nocturnal hemoglobinuria medications")
- 00:11, 27 December 2022 Jwarner talk contribs created page Category:Anti-GPRC5D antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 00:10, 27 December 2022 Jwarner talk contribs created page Talquetamab (JNJ-64407564) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talquetamab NCI Drug Dictionary]: A bispecific humanized monoclonal antibody...")
- 00:02, 27 December 2022 Jwarner talk contribs created page Glofitamab (RO 7082859) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glofitamab NCI Drug Dictionary]: A bispecific monoclonal antibody, with pote...")
- 21:10, 26 December 2022 Jwarner talk contribs moved page Adagrasib (MRTX849) to Adagrasib (Krazati) (FDA approval)
- 12:35, 26 December 2022 Jwarner talk contribs created page Nadofaragene firadenovec (Adstiladrin) (Created page with "==General information== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec NCI Drug Dictionary]: A replication-deficient recom...")
- 12:33, 25 December 2022 Jwarner talk contribs created page Category:Renal cell carcinoma medications (investigational) (Created page with "Category:Renal cell carcinoma medications")
- 12:33, 25 December 2022 Jwarner talk contribs created page Vorolanib (CM-082) (Created page with "=Mechanism of action= From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib NCI Drug Dictionary]: An orally available small molecule dual inhibi...")
- 12:30, 25 December 2022 Jwarner talk contribs created page Category:Thyroid cancer, differentiated medications (investigational) (Created page with "Category:Thyroid cancer, differentiated medications")
- 12:29, 25 December 2022 Jwarner talk contribs created page Category:Thyroid cancer medications (investigational) (Created page with "Category:Thyroid cancer medications")
- 12:00, 25 December 2022 Jwarner talk contribs created page Mosunetuzumab (Lunsumio) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab NCI Drug Dictionary]: A bispecific, humanized monoclonal antib...")
- 12:55, 11 December 2022 Jwarner talk contribs created page Category:Alveolar soft part sarcoma medications (Created page with "Category:Sarcoma medications")
- 12:38, 4 December 2022 Jwarner talk contribs moved page NEOD001 to Birtamimab (NEOD001)
- 12:36, 4 December 2022 Jwarner talk contribs moved page Hu5F9-G4 to Magrolimab (Hu5F9-G4)
- 12:21, 4 December 2022 Jwarner talk contribs moved page AMG 330 to Eluvixtamab (AMG 330)
- 14:00, 3 December 2022 Jwarner talk contribs created page Melanoma, BRAF-mutated - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 13:52, 3 December 2022 Jwarner talk contribs moved page Acute myeloid leukemia, FLTE3-positive - null regimens to Acute myeloid leukemia, FLT3-positive - null regimens
- 13:10, 3 December 2022 Jwarner talk contribs created page Acute myeloid leukemia, FLTE3-positive - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:48, 3 December 2022 Jwarner talk contribs created page Tirapazamine (SR 4233) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A benzotriazine di-N-oxide with potential antineoplastic activity. Tirapazamine is selectively activated by multiple redu...")
- 00:46, 3 December 2022 Jwarner talk contribs created page Category:Anti-GP-3 antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 00:46, 3 December 2022 Jwarner talk contribs created page Farletuzumab (MORAb-003) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A humanized, immunoglobulin G1 monoclonal antibody with potential antitumor activity. Farletuzumab specifically targets a...")
- 00:45, 3 December 2022 Jwarner talk contribs created page Category:TLR9 agonists (Created page with "Category:Immunotherapeutic")
- 00:44, 3 December 2022 Jwarner talk contribs created page Agatolimod (PF-3512676) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: The tricosasodium salt of a synthetic 24-mer oligonucleotide containing 3 CpG motifs with potential antineoplastic and im...")
- 00:42, 3 December 2022 Jwarner talk contribs created page Category:Vascular disrupting agents (Created page with "Category:Targeted therapeutic")
- 00:38, 3 December 2022 Jwarner talk contribs created page Vadimezan (ASA404) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines...")
- 00:36, 3 December 2022 Jwarner talk contribs created page Figitumumab (CP-751,871) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antine...")
- 00:35, 3 December 2022 Jwarner talk contribs created page Category:Matrix metalloproteinase inhibitors (Created page with "Category:Enzyme inhibitors")
- 00:34, 3 December 2022 Jwarner talk contribs created page BMS-275291 (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bms-275291 NCI Drug Dictionary]: A substance that is being studied in the t...")
- 23:40, 2 December 2022 Jwarner talk contribs created page Olutasidenib (Rezlidhia) (Created page with "==General information== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olutasidenib NCI Drug Dictionary]: An orally available inhibitor of isocitra...")
- 00:19, 15 November 2022 Jwarner talk contribs created page Category:Anti-FOLR1 antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 00:19, 15 November 2022 Jwarner talk contribs created page Mirvetuximab soravtansine (Elahere) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirvetuximab-soravtansine NCI Drug Dictionary]: An immunoconjugate consistin...")
- 20:37, 11 November 2022 Jwarner talk contribs created page User:Sanjaymishra (Created page with "Here is Sanjay's page")
- 12:20, 9 November 2022 Jwarner talk contribs created page Furmonertinib (Ivesa) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate NCI Drug Dictionary]: The mesylate salt form of alflutin...")
- 02:31, 9 November 2022 Jwarner talk contribs created page Category:Thyroid cancer, medullary medications (Created page with "Category:Thyroid cancer medications")
- 22:45, 8 November 2022 Jwarner talk contribs created page Category:EMA approved in 2020 (Created page with "Category:EMA approved in the 2020s")
- 15:40, 7 November 2022 Jwarner talk contribs moved page Teclistamab (JNJ 64007957) to Teclistamab (Tecvayli)
- 10:31, 5 November 2022 Jwarner talk contribs moved page Sutimlimab (BIVV009) to Sutimlimab (Enjaymo) (FDA approval)
- 21:43, 24 October 2022 Jwarner talk contribs moved page Tremelimumab (ticilimumab) to Tremelimumab (Imjudo) (FDA approval)
- 12:31, 24 October 2022 Jwarner talk contribs created page Therapeutic equivalents (Created page with "'''This page is very much under construction at the moment.''' =Introduction= Generally speaking, prospective clinical trials are very specific in the drugs that they use in t...")
- 14:46, 12 October 2022 Jwarner talk contribs created page Bevacizumab-adcd (Vegzelga) (Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Bevacizumab (Avastin) page, except for the details of FDA indication.''' ==Genera...")
- 13:00, 10 October 2022 Jwarner talk contribs created page Cervical cancer - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:51, 10 October 2022 Jwarner talk contribs created page Buserelin (Suprefact) (Created page with "==Mechanism of action== Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis. ==Di...")
- 13:48, 8 October 2022 Jwarner talk contribs created page Staging page (Created blank page)
- 18:47, 3 October 2022 Jwarner talk contribs created page Elacestrant (RAD1901) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacestrant NCI Drug Dictionary]: An orally available, selective estrogen re...")
- 21:02, 30 September 2022 Jwarner talk contribs created page Futibatinib (Lytgobi) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futibatinib NCI Drug Dictionary]: An orally bioavailable inh...")
- 13:29, 30 September 2022 Jwarner talk contribs created page Envafolimab (KN 035) (Created page with "==General information== Class/mechanism: PD-L1 antibody. <br>Route: IV <br>Extravasation: no information For conciseness and simplicity, HemOnc.org currently will focus on tr...")
- 13:20, 30 September 2022 Jwarner talk contribs created page Penpulimab (AK105) (Created page with "'''Note: Penpulimab is approved in China, but does not appear to have a brand name at this time.''' ==Mechanism of action== PD-1 inhibitor ==Diseases for which it is used== *...")
- 13:17, 30 September 2022 Jwarner talk contribs created page Zimberelimab (AB122) (Created page with "'''Note: Zimberelimab is approved in China, but does not appear to have a brand name at this time.''' ==Mechanism of action== PD-1 inhibitor ==Diseases for which it is used==...")
- 12:50, 30 September 2022 Jwarner talk contribs created page Sugemalimab (Cejemly) (Created page with "==General information== Class/mechanism: PD-L1 blocking antibody. PD-L1 (programmed death-1 ligand 1) expressed on tumor cells and tumor-infiltrating immune cells can result i...")
- 11:17, 30 September 2022 Jwarner talk contribs created page Serplulimab (Hansizhuang) (Created page with "==General information== Class/mechanism: PD-1 receptor antibody. <br>Route: IV <br>Extravasation: no information For conciseness and simplicity, HemOnc.org currently will foc...")
- 23:38, 29 September 2022 Jwarner talk contribs created page Rezvilutamide (SHR3680) (Created page with "==Mechanism of action== A nonsteroidal antiandrogen. ==Preliminary data== ===Prostate cancer=== #'''CHART:''' Gu W, Han W, Luo H, Zhou F, He D, Ma L, Guo H, Liang C, Chon...")
- 23:14, 28 September 2022 Jwarner talk contribs created page Category:Anti-GPRC5D cellular therapy (Created page with "Category:Cellular therapy")
- 23:13, 28 September 2022 Jwarner talk contribs created page MCARH109 (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-gprc5d-car-4-1bb-expressing-t-cells-mcarh109 NCI Drug Dictio...")
- 20:31, 28 September 2022 Jwarner talk contribs created page D5NS (Created page with "IV fluid consisting of 5% Dextrose and 0.9% Sodium Chloride Category:Hydration Category:Stub")
- 12:19, 26 September 2022 Jwarner talk contribs created page Category:Hydration (Created page with "A category of fluids intended for intravenous hydration. Category:Supportive medications")
- 12:18, 26 September 2022 Jwarner talk contribs created page Normal saline (Created page with "IV fluid Category:Hydration Category:Stub")
- 10:59, 20 September 2022 Jwarner talk contribs created page Aumolertinib (Amelie) (Created page with "==General information== Class/mechanism: Third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). <br>Route: PO <br>Extravasation: n/a ==Dise...")
- 23:11, 16 September 2022 Jwarner talk contribs created page Desmoid tumor - null regimens (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 16:20, 16 September 2022 Jwarner talk contribs created page Lanreotide LAR (Somatuline Depot) (Created page with "==General information== Class/mechanism: Long-acting dosage form of Lanreotide (Somatuline). For conciseness and simplicity, HemOnc.org currently will focus on treatmen...")
- 00:33, 8 September 2022 Jwarner talk contribs moved page Chronic myelogenous leukemia - historical to Chronic myeloid leukemia - historical
- 17:34, 6 September 2022 Jwarner talk contribs moved page Pimitespib (TAS-116) to Pimitespib (Jeselhy) (PMDA approval)
- 13:58, 6 September 2022 Jwarner talk contribs created page Pimitespib (TAS-116) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimitespib NCI Drug Dictionary]: A specific inhibitor of heat shock protein...")
- 11:20, 2 September 2022 Jwarner talk contribs created page Category:Inherited coagulopathy medications (investigational) (Created page with "Category:Inherited coagulopathy medications")
- 11:19, 2 September 2022 Jwarner talk contribs created page Verbrinacogene setparvovec (FLT180a) (Created page with "Gene therapy ==Preliminary data== ===Hemophilia B=== #'''B-AMAZE:''' Chowdary P, Shapiro S, Makris M, Evans G, Boyce S, Talks K, Dolan G, Reiss U,...")
- 10:52, 2 September 2022 Jwarner talk contribs created page Adagrasib (MRTX849) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagrasib NCI Drug Dictionary]: An orally available, small molecule inhibito...")
- 18:14, 30 August 2022 Jwarner talk contribs moved page Quizartinib (AC220) to Quizartinib (Vanflyta) (PMDA approved)
- 19:52, 25 August 2022 Jwarner talk contribs moved page Chronic myelogenous leukemia, pediatric to Chronic myeloid leukemia, pediatric (Concordance with ICC naming conventions)
- 19:51, 25 August 2022 Jwarner talk contribs moved page Chronic myelogenous leukemia to Chronic myeloid leukemia (Concordance with ICC terminology)
- 13:45, 23 August 2022 Jwarner talk contribs created page Category:Juvenile myelomonocytic leukemia medications (Created page with "Category:Acute leukemia medications")
- 13:45, 23 August 2022 Jwarner talk contribs created page Category:Juvenile myelomonocytic leukemia regimens (Created page with "Category:Leukemia regimens")
- 13:44, 23 August 2022 Jwarner talk contribs created page Juvenile myelomonocytic leukemia (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 10:40, 9 August 2022 Jwarner talk contribs moved page Ewing Sarcoma, pediatric to Ewing sarcoma, pediatric (consistent capitalization)
- 10:35, 9 August 2022 Jwarner talk contribs moved page Ewing Sarcoma - historical to Ewing sarcoma, pediatric - historical
- 14:24, 29 July 2022 Jwarner talk contribs moved page B-cell acute lymphoblastic leukemia, Ph-positive, pediatric to B-cell acute lymphoblastic leukemia, pediatric, Ph-positive
- 14:02, 5 July 2022 Jwarner talk contribs created page Category:High-grade glioma, pediatric medications (Created page with "Category:High-grade glioma medications")
- 13:30, 5 July 2022 Jwarner talk contribs created page Category:High-grade glioma, pediatric medications (investigational) (Created page with "Category:High-grade glioma, pediatric medications")
- 13:30, 5 July 2022 Jwarner talk contribs created page Tasadenoturev (DNX-2401) (Created page with "==Mechanism of action== Oncolytic virus ==Preliminary data== ===High-grade glioma, pediatric=== #'''D24-DIPG:''' Gállego Pérez-Larraya J, Garcia-Moure M, Labiano S, Pat...")
- 23:34, 12 June 2022 Jwarner talk contribs created page Category:Small cell lung cancer medications (investigational) (Created page with "Category:Small cell lung cancer medications")
- 23:33, 12 June 2022 Jwarner talk contribs created page Adebrelimab (SHR-1316) (Created page with "Category:Drugs Category:Intravenous medications Category:T-cell activators Category:Anti-PD-L1 antibodies Category:Small cell lung cancer medications (inv...")
- 01:52, 2 June 2022 Jwarner talk contribs created page Marginal zone lymphoma - historical (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 01:42, 2 June 2022 Jwarner talk contribs created page Category:FDA withdrawn in 2022 (Created page with "Category:Discontinued drugs")
- 01:42, 2 June 2022 Jwarner talk contribs created page Category:Marginal zone lymphoma medications (historic) (Created page with "Category:Marginal zone lymphoma medications")
- 13:06, 22 May 2022 Jwarner talk contribs created page Adult T-cell leukemia-lymphoma - historical (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 01:49, 14 May 2022 Jwarner talk contribs created page Category:Local therapies (Created page with "Drugs or devices that are used with a local effect, as opposed to a systemic (whole body) effect. Category:Drugs")
- 00:16, 9 May 2022 Jwarner talk contribs created page Category:Non-clear cell renal cell carcinoma medications (Created page with "Category:Renal cell carcinoma medications")
- 00:14, 9 May 2022 Jwarner talk contribs created page Category:Clear cell renal cell carcinoma medications (Created page with "Category:Renal cell carcinoma medications")
- 00:11, 9 May 2022 Jwarner talk contribs created page Category:Non-clear cell renal cell carcinoma regimens (Created page with "Category:Renal cell carcinoma regimens")
- 00:10, 9 May 2022 Jwarner talk contribs created page Non-clear cell renal cell carcinoma (Created page with "{{#lst:Section editor transclusions|gu}} ''Are you looking for a regimen but can't find it here? It is possible that we've moved it to the Renal_cell_carcinoma_-_historical|...")
- 00:10, 9 May 2022 Jwarner talk contribs created page Category:Clear cell renal cell carcinoma regimens (Created page with "Category:Renal cell carcinoma regimens")
- 00:10, 9 May 2022 Jwarner talk contribs created page Clear cell renal cell carcinoma (Created page with "{{#lst:Section editor transclusions|gu}} ''Are you looking for a regimen but can't find it here? It is possible that we've moved it to the Renal_cell_carcinoma_-_historical|...")
- 14:13, 5 May 2022 Jwarner talk contribs moved page Toripalimab (JS001) to Toripalimab (Tuoyi) (NMPA approval)
- 14:05, 5 May 2022 Jwarner talk contribs created page Category:Esophageal squamous cell carcinoma medications (investigational) (Created page with "Category:Esophageal squamous cell carcinoma medications")
- 22:36, 1 May 2022 Jwarner talk contribs created page Category:Thyroid cancer, differentiated medications (Created page with "Medications with some demonstrated degree of efficacy in the treatment of differentiated thyroid cancer (DTC).")
- 21:31, 1 May 2022 Jwarner talk contribs created page Category:Malignant pleural mesothelioma medications (Created page with "Drugs with some demonstrated degree of efficacy in the treatment of malignant pleural mesothelioma. Category:Mesothelioma medications")
- 16:29, 1 May 2022 Jwarner talk contribs created page Category:Histology-specific medications (Created page with "Medications which are grouped by a certain histology (e.g., sarcoma, mesothelioma) rather than a body location. However it should be noted that histology and body site are oft...")
- 16:24, 1 May 2022 Jwarner talk contribs moved page Malignant Pleural Mesothelioma to Malignant pleural mesothelioma
- 16:23, 1 May 2022 Jwarner talk contribs created page Category:Mesotheliomas (Created page with "Category:Malignant solid neoplasm")
- 16:14, 1 May 2022 Jwarner talk contribs created page Category:Non-small cell lung cancer, squamous medications (Created page with "Category:Non-small cell lung cancer medications")
- 16:14, 1 May 2022 Jwarner talk contribs created page Category:Non-small cell lung cancer, nonsquamous medications (Created page with "Category:Non-small cell lung cancer medications")
- 16:13, 1 May 2022 Jwarner talk contribs created page Category:Malignant peritoneal mesothelioma medications (Created page with "Drugs with some demonstrated degree of efficacy in the treatment of malignant peritoneal mesothelioma. Category:Gastrointestinal cancer medications")
- 16:06, 1 May 2022 Jwarner talk contribs moved page Malignant Peritoneal Mesothelioma to Malignant peritoneal mesothelioma (Capitalization)
- 14:22, 1 May 2022 Jwarner talk contribs created page Category:Gestational trophoblastic neoplasia medications (historic) (Created page with "Category:Gestational trophoblastic neoplasia medications")
- 01:53, 1 May 2022 Jwarner talk contribs created page Category:Esophageal cancer medications (investigational) (Created page with "Category:Esophageal cancer medications")
- 01:52, 1 May 2022 Jwarner talk contribs created page Category:Esophageal squamous cell carcinoma medications (Created page with "Medications with some demonstrated degree of efficacy in the treatment of esophageal squamous cell carcinoma. Category:Esophageal cancer medications")
- 01:20, 1 May 2022 Jwarner talk contribs created page Category:Esophageal adenocarcinoma medications (Created page with "Medications with some demonstrated degree of efficacy in the treatment of esophageal adenocarcinoma. Category:Esophageal cancer medications")
- 01:11, 1 May 2022 Jwarner talk contribs moved page Desmoid tumors to Desmoid tumor (Naming convention)
- 01:51, 30 April 2022 Jwarner talk contribs created page Colorectal cancer, RAS wild-type (Created page with "{{#lst:Section editor transclusions|gi}} <big>Note: the page has systemic regimens for the more general category of RAS wild-type colorectal cancer. Also note that most of the...")
- 01:38, 30 April 2022 Jwarner talk contribs created page Colorectal cancer - null regimens (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 01:23, 30 April 2022 Jwarner talk contribs created page Colorectal cancer - historical (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 01:05, 30 April 2022 Jwarner talk contribs moved page Colon cancer, MSI-H or dMMR to Colorectal cancer, MSI-H or dMMR
- 01:05, 30 April 2022 Jwarner talk contribs moved page Colon cancer, HER2-positive to Colorectal cancer, HER2-positive (Re-organization)
- 01:04, 30 April 2022 Jwarner talk contribs moved page Colon cancer, BRAF-mutated to Colorectal cancer, BRAF-mutated (Re-organization)
- 00:58, 30 April 2022 Jwarner talk contribs created page Colorectal cancer (Created page with "{{#lst:Section editor transclusions|gi}} ''Are you looking for a regimen, but can't find it here? It is possible that we've moved it to the Colorectal_cancer_-_historical|hi...")
- 00:32, 30 April 2022 Jwarner talk contribs created page Category:Colorectal cancer medications (Created page with "Category:Gastrointestinal oncology medications")
- 00:31, 30 April 2022 Jwarner talk contribs created page Category:Colorectal cancer medications (investigational) (Created page with "Category:Colorectal cancer medications")
- 00:27, 30 April 2022 Jwarner talk contribs created page Category:Chronic myelogenous leukemia medications (investigational) (Created page with "Category:Chronic myelogenous leukemia medications")
- 00:26, 30 April 2022 Jwarner talk contribs created page Category:B-cell acute lymphoblastic leukemia medications (investigational) (Created page with "Category:B-cell acute lymphoblastic leukemia medications")
- 00:09, 30 April 2022 Jwarner talk contribs created page Category:Colon cancer medications (investigational) (Created page with "Category:Colon cancer medications")
- 21:48, 29 April 2022 Jwarner talk contribs created page Category:Anti-CD19 cellular therapy (Created page with "Category:Cellular therapy")
- 21:17, 29 April 2022 Jwarner talk contribs created page Category:Anti-CD137 cellular therapy (Created page with "Category:Cellular therapy")
- 21:17, 29 April 2022 Jwarner talk contribs created page Category:Anti-BCMA cellular therapy (Created page with "Category:Cellular therapy")
- 21:11, 29 April 2022 Jwarner talk contribs created page Category:Anti-CD28 cellular therapy (Created page with "Category:Cellular therapy")
- 21:11, 29 April 2022 Jwarner talk contribs created page Category:Anti-CD20 cellular therapy (Created page with "Category:Cellular therapy")
- 21:11, 29 April 2022 Jwarner talk contribs created page Category:Anti-CD3 cellular therapy (Created page with "Category:Cellular therapy")
- 20:42, 29 April 2022 Jwarner talk contribs created page Category:Cold agglutinin disease medications (investigational) (Created page with "Category:Cold agglutinin disease medications")
- 20:30, 29 April 2022 Jwarner talk contribs created page Category:Adrenal suppressant (Created page with "Category:Endocrine therapeutic")
- 20:25, 29 April 2022 Jwarner talk contribs created page Category:Epothilones (Created page with "Category:Antitumor antibiotics")
- 20:22, 29 April 2022 Jwarner talk contribs created page Category:Antitumor antibiotics (Created page with "Category:Cytotoxic chemotherapeutic")
- 02:21, 29 April 2022 Jwarner talk contribs created page Category:Nasopharyngeal carcinoma medications (investigational) (Created page with "Category:Nasopharyngeal carcinoma medications")
- 02:21, 29 April 2022 Jwarner talk contribs created page Category:Head and neck cancer medications (investigational) (Created page with "Category:Head and neck cancer medications")
- 02:14, 29 April 2022 Jwarner talk contribs created page Category:Heparin-induced thrombocytopenia medications (historic) (Created page with "Category:Heparin-induced thrombocytopenia medications")
- 02:14, 29 April 2022 Jwarner talk contribs created page Category:Venous thromboembolism medications (historic) (Created page with "Category:Venous thromboembolism medications")
- 00:45, 29 April 2022 Jwarner talk contribs created page Chronic myelogenous leukemia - historical (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 00:32, 29 April 2022 Jwarner talk contribs created page Category:Chronic myelogenous leukemia medications (historic) (Created page with "Category:Chronic myelogenous leukemia medications")
- 00:22, 29 April 2022 Jwarner talk contribs created page Category:Waldenström macroglobulinemia medications (historic) (Created page with "Category:Waldenström macroglobulinemia medications")
- 02:18, 28 April 2022 Jwarner talk contribs created page Category:Mesothelioma medications (investigational) (Created page with "Category:Mesothelioma medications")
- 02:17, 28 April 2022 Jwarner talk contribs created page Category:Peripheral T-cell lymphoma medications (investigational) (Created page with "Category:Peripheral T-cell lymphoma medications")
- 02:15, 28 April 2022 Jwarner talk contribs created page Category:Hodgkin lymphoma medications (investigational) (Created page with "Category:Hodgkin lymphoma medications")
- 14:49, 27 April 2022 Jwarner talk contribs created page Category:Chronic lymphocytic leukemia medications (investigational) (Created page with "Category:Chronic lymphocytic leukemia medications")
- 14:48, 27 April 2022 Jwarner talk contribs created page Category:Chronic lymphocytic leukemia medications (historic) (Created page with "Category:Chronic lymphocytic leukemia medications")
- 12:07, 27 April 2022 Jwarner talk contribs created page Category:Gastric cancer medications (historic) (Created page with "Category:Gastric cancer medications")
- 02:05, 27 April 2022 Jwarner talk contribs created page Category:Kaposi sarcoma medications (historic) (Created page with "Category:Kaposi sarcoma medications")
- 17:21, 26 April 2022 Jwarner talk contribs created page Category:Multiple myeloma medications (investigational) (Created page with "Category:Multiple myeloma medications")
- 13:49, 26 April 2022 Jwarner talk contribs created page Category:Ovarian cancer medications (investigational) (Created page with "Category:Ovarian cancer medications")
- 13:47, 26 April 2022 Jwarner talk contribs created page Category:Breast cancer medications (investigational) (Created page with "Category:Breast cancer medications")
- 13:47, 26 April 2022 Jwarner talk contribs created page Category:Non-small cell lung cancer medications (investigational) (Created page with "Category:Non-small cell lung cancer medications")
- 13:46, 26 April 2022 Jwarner talk contribs created page Category:Prostate cancer medications (investigational) (Created page with "Category:Prostate cancer medications")
- 11:43, 26 April 2022 Jwarner talk contribs created page Category:Systemic mastocytosis medications (investigational) (Created page with "Category:Systemic mastocytosis medications")
- 11:41, 26 April 2022 Jwarner talk contribs created page Category:Gastrointestinal stromal tumor medications (investigational) (Created page with "Category:Gastrointestinal stromal tumor medications")
- 11:41, 26 April 2022 Jwarner talk contribs created page Category:Pancreatic cancer medications (investigational) (Created page with "Category:Pancreatic cancer medications")
- 11:39, 26 April 2022 Jwarner talk contribs created page Category:Pancreatic cancer medications (historic) (Created page with "Category:Pancreatic cancer medications")
- 02:18, 26 April 2022 Jwarner talk contribs created page Category:Soft tissue sarcoma medications (investigational) (Created page with "Category:Soft tissue sarcoma medications")
- 02:18, 26 April 2022 Jwarner talk contribs created page Category:Osteosarcoma medications (investigational) (Created page with "Category:Osteosarcoma medications")
- 02:18, 26 April 2022 Jwarner talk contribs created page Category:Adrenocortical carcinoma medications (investigational) (Created page with "Category:Adrenocortical carcinoma medications")
- 02:18, 26 April 2022 Jwarner talk contribs created page Category:Thymoma medications (investigational) (Created page with "Category:Thymoma medications")
- 02:16, 26 April 2022 Jwarner talk contribs created page Category:Head and neck cancer medications (historic) (Created page with "Category:Head and neck cancer medications")
- 02:16, 26 April 2022 Jwarner talk contribs created page Category:Osteosarcoma medications (historic) (Created page with "Category:Osteosarcoma medications")
- 01:57, 26 April 2022 Jwarner talk contribs created page Category:Acute myeloid leukemia medications (investigational) (Created page with "Category:Acute myeloid leukemia medications")
- 01:56, 26 April 2022 Jwarner talk contribs created page Category:Acute myeloid leukemia medications (historic) (Created page with "Category:Acute myeloid leukemia medications")
- 01:55, 26 April 2022 Jwarner talk contribs created page Category:B-cell acute lymphoblastic leukemia medications (historic) (Created page with "Category:B-cell acute lymphoblastic leukemia medications")
- 23:38, 25 April 2022 Jwarner talk contribs created page Category:Transformed lymphoma medications (historic) (Created page with "Category:Transformed lymphoma medications")
- 21:47, 25 April 2022 Jwarner talk contribs created page Category:Hodgkin lymphoma medications (historic) (Created page with "Category:Hodgkin lymphoma medications")
- 21:47, 25 April 2022 Jwarner talk contribs created page Category:Small cell lung cancer medications (historic) (Created page with "Category:Small cell lung cancer medications")
- 21:45, 25 April 2022 Jwarner talk contribs created page Category:Diffuse large B-cell lymphoma medications (historic) (Created page with "Category:Diffuse large B-cell lymphoma medications")
- 21:31, 25 April 2022 Jwarner talk contribs created page Category:Diffuse large B-cell lymphoma medications (investigational) (Created page with "Category:Diffuse large B-cell lymphoma medications")
- 21:30, 25 April 2022 Jwarner talk contribs created page Category:Follicular lymphoma medications (investigational) (Created page with "Category:Follicular lymphoma medications")
- 21:30, 25 April 2022 Jwarner talk contribs created page Category:Mantle cell lymphoma medications (investigational) (Created page with "Category:Mantle cell lymphoma medications")
- 21:29, 25 April 2022 Jwarner talk contribs created page Category:Follicular lymphoma medications (historic) (Created page with "Category:Follicular lymphoma medications")
- 21:26, 25 April 2022 Jwarner talk contribs created page Category:Bladder cancer medications (investigational) (Created page with "Category:Bladder cancer medications")
- 21:25, 25 April 2022 Jwarner talk contribs created page Category:Bladder cancer medications (historic) (Created page with "Category:Bladder cancer medications")
- 21:18, 25 April 2022 Jwarner talk contribs created page Category:Non-small cell lung cancer medications (historic) (Created page with "Category:Non-small cell lung cancer medications")
- 21:15, 25 April 2022 Jwarner talk contribs created page Category:Soft tissue sarcoma medications (historic) (Created page with "Category:Soft tissue sarcoma medications")
- 19:54, 25 April 2022 Jwarner talk contribs created page Category:Medulloblastoma medications (historic) (Created page with "Category:Medulloblastoma medications")
- 19:54, 25 April 2022 Jwarner talk contribs created page Category:Light-chain (AL) amyloidosis medications (historic) (Created page with "Category:Light-chain (AL) amyloidosis medications")
- 19:47, 25 April 2022 Jwarner talk contribs created page Category:Smoldering multiple myeloma medications (Created page with "Category:Plasma cell dyscrasia medications")
- 19:43, 25 April 2022 Jwarner talk contribs created page Category:Renal cell carcinoma medications (historic) (Created page with "Category:Renal cell carcinoma medications")
- 19:37, 25 April 2022 Jwarner talk contribs created page Category:Testicular cancer medications (historic) (Created page with "Category:Testicular cancer medications")
- 19:36, 25 April 2022 Jwarner talk contribs created page Category:Ovarian cancer medications (historic) (Created page with "Category:Ovarian cancer medications")
- 19:08, 25 April 2022 Jwarner talk contribs created page Category:MALT lymphoma medications (historic) (Created page with "Category:MALT lymphoma medications")
- 19:00, 25 April 2022 Jwarner talk contribs created page Category:Indolent lymphoma medications (Created page with "Category:Lymphoma medications")
- 19:00, 25 April 2022 Jwarner talk contribs created page Category:MALT lymphoma medications (Created page with "Drugs which have shown some degree of efficacy in MALT lymphoma. Category:Indolent lymphoma medications")
- 18:53, 25 April 2022 Jwarner talk contribs created page Category:Melanoma medications (historic) (Created page with "Category:Melanoma medications")
- 18:53, 25 April 2022 Jwarner talk contribs created page Category:Hepatocellular carcinoma medications (historic) (Created page with "Category:Hepatocellular carcinoma medications")
- 18:49, 25 April 2022 Jwarner talk contribs created page Category:Peripheral T-cell lymphoma medications (historic) (Created page with "Category:Peripheral T-cell lymphoma medications")
- 18:46, 25 April 2022 Jwarner talk contribs created page Category:Multiple myeloma medications (historic) (Created page with "Medications that had a role in the treatment of multiple myeloma at one point in time. Category:Multiple myeloma medications")
- 16:46, 25 April 2022 Jwarner talk contribs created page Category:Prostate cancer medications (historic) (Created page with "Category:Prostate cancer medications")
- 13:47, 25 April 2022 Jwarner talk contribs created page Category:Malignant pleural mesothelioma regimens (Created page with "Category:Mesothelioma regimens")
- 13:47, 25 April 2022 Jwarner talk contribs created page Category:Malignant peritoneal mesothelioma regimens (Created page with "Category:Mesothelioma regimens")
- 13:46, 25 April 2022 Jwarner talk contribs created page Malignant Peritoneal Mesothelioma (Created page with "{{#lst:Section editor transclusions|gi}} {| class="wikitable" style="float:right; margin-right: 5px;" |- |<div style="background-color: #fee0d1; border: 1px solid #808000; pad...")
- 13:41, 25 April 2022 Jwarner talk contribs moved page Mesothelioma to Malignant Pleural Mesothelioma (creating new peritoneal mesothelioma page)
- 13:39, 25 April 2022 Jwarner talk contribs created page Category:Appendiceal tumor regimens (Created page with "Category:Gastrointestinal (GI) oncology regimens")
- 13:39, 25 April 2022 Jwarner talk contribs created page Appendiceal tumor (Created page with "{{#lst:Section editor transclusions|gi}} {| class="wikitable" style="float:right; margin-right: 5px;" |- |<div style="background-color: #fee0d1; border: 1px solid #808000; pad...")
- 12:10, 22 April 2022 Jwarner talk contribs moved page Sintilimab (IBI 308) to Sintilimab (Tyvyt) (Approval)
- 12:08, 22 April 2022 Jwarner talk contribs moved page Category:CFDA approved drugs to Category:NMPA approved drugs (agency renamed)
- 12:08, 14 April 2022 Jwarner talk contribs created page Rilzabrutinib (PRN-1008) (Created page with "==General information== Class/mechanism: BTK inhibitor <br>Route: PO <br>Extravasation: n/a ==Preliminary data== ===Immune thrombocytopenia=== #'''PRN1008-010:''' Kuter D...")
- 00:50, 26 March 2022 Jwarner talk contribs moved page Medullary thyroid cancer to Thyroid cancer, medullary (naming convention)
- 00:50, 26 March 2022 Jwarner talk contribs moved page Differentiated thyroid cancer to Thyroid cancer, differentiated (naming convention)
- 00:16, 26 March 2022 Jwarner talk contribs moved page Pacritinib (SB1518) to Pacritinib (Vonjo) (FDA approval)
- 22:07, 22 March 2022 Jwarner talk contribs created page Category:Combination drugs (Created page with "Drugs with 2 or more active components. This does not include drugs with a vehicle such as hyaluronidase. Category:Drugs")
- 21:53, 22 March 2022 Jwarner talk contribs moved page Relatlimab (BMS-986016) to Nivolumab and relatlimab (Opdualag) (FDA approval)
- 15:11, 3 March 2022 Jwarner talk contribs moved page Ciltacabtagene autoleucel (JNJ-68284528) to Ciltacabtagene autoleucel (Carvykti) (FDA approval)
- 03:05, 27 February 2022 Jwarner talk contribs created page Fludrocortisone (Florinef) (Created page with "Mineralocorticoid Category:Drugs Category:Steroids Category:Stub")
- 16:53, 17 February 2022 Jwarner talk contribs created page Talk:Vesicant & irritant chemotherapy (Created page with "Notes here about what additional vesicants to add. ~~~")
- 22:28, 27 January 2022 Jwarner talk contribs moved page Tebentafusp (IMCgp100) to Tebentafusp (Kimmtrak) (FDA approval)
- 22:27, 27 January 2022 Jwarner talk contribs created page Category:FDA approved in 2022 (Created page with "Category:FDA approved in the 2020s")
- 00:49, 20 January 2022 Jwarner talk contribs created page Non-small cell lung cancer, HER2-mutated (Created page with "{{#lst:Section editor transclusions|nsclc}} Note: these are regimens tested in biomarker-specific populations, please see the '''main NSCLC page...")
- 00:41, 20 January 2022 Jwarner talk contribs moved page Fam-trastuzumab deruxtecan (Enhertu) to Trastuzumab deruxtecan (Enhertu)
- 13:15, 6 January 2022 Jwarner talk contribs created page Category:Anti-LAG-3 antibodies (Created page with "Category:Immunostimulatory monoclonal antibodies")
- 13:15, 6 January 2022 Jwarner talk contribs created page Relatlimab (BMS-986016) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A monoclonal antibody directed against the inhibitor receptor lymphocyte activation gene-3 (LAG-3), with potential immune...")
- 17:46, 20 December 2021 Jwarner talk contribs created page Suramin (Antrypol) (Created page with "==Mechanism of action== Antiparasitic with mechanism of action unclear. ==Diseases for which it was used== *Prostate cancer ==History of changes in FDA indication== *Thi...")
- 02:08, 19 December 2021 Jwarner talk contribs created page Category:Tenosynovial giant cell tumor regimens (Created page with "Category:Soft tissue sarcoma regimens")
- 02:07, 19 December 2021 Jwarner talk contribs created page Tenosynovial giant cell tumor (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 01:56, 19 December 2021 Jwarner talk contribs created page Category:Tenosynovial giant cell tumor medications (Created page with "Category:Soft tissue sarcoma medications")
- 22:38, 17 December 2021 Jwarner talk contribs created page Category:PEComa regimens (Created page with "Category:Soft tissue sarcoma regimens")
- 22:38, 17 December 2021 Jwarner talk contribs created page PEComa (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 22:32, 17 December 2021 Jwarner talk contribs created page Category:PEComa medications (Created page with "Category:Sarcoma medications")
- 22:31, 17 December 2021 Jwarner talk contribs created page Sirolimus protein-bound particles (Fyarro) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: The macrolide antibiotic rapamycin bound to nanoparticle albumin with immunosuppressant (see sirolimus) and potential ant...")
- 15:57, 17 December 2021 Jwarner talk contribs created page Tebentafusp (IMCgp100) (Created page with "==Mechanism of action== Bispecific protein consisting of an affinity-enhanced T-cell receptor fused to an anti-CD3 effector that can redirect T cells to target glycoprotein 10...")
- 14:15, 12 December 2021 Jwarner talk contribs created page Category:Subependymal giant cell astrocytoma medications (Created page with "Category:Low-grade glioma medications")
- 14:09, 12 December 2021 Jwarner talk contribs created page Category:Subependymal giant cell astrocytoma regimens (Created page with "Category:Neuro-oncology regimens")
- 14:08, 12 December 2021 Jwarner talk contribs created page Subependymal giant cell astrocytoma (Created page with "{| class="wikitable" style="text-align:center; width:50%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Section editor''' |-...")
- 12:13, 10 December 2021 Jwarner talk contribs created page Category:EMA approved in 2005 (Created page with "Category:EMA approved in the 2000s")
- 03:02, 10 December 2021 Jwarner talk contribs created page Category:FDA withdrawn in 2013 (Created page with "Category:Discontinued drugs")
- 02:54, 10 December 2021 Jwarner talk contribs created page Peripheral T-cell lymphoma - historical (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 02:43, 10 December 2021 Jwarner talk contribs created page Category:FDA withdrawn in 2020 (Created page with "Category:Discontinued drugs")
- 23:38, 8 December 2021 Jwarner talk contribs created page Category:STAMP inhibitors (Created page with "Category:Bcr-Abl inhibitors")
- 13:20, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 1999 (Created page with "Category:EMA approved in the 1990s")
- 13:18, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 1998 (Created page with "Category:EMA approved in the 1990s")
- 03:43, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 1996 (Created page with "Category:EMA approved in the 1990s")
- 03:23, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in the 2020s (Created page with "Category:EMA approved in the 21st century")
- 03:23, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2021 (Created page with "Category:EMA approved in the 2020s")
- 03:20, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2019 (Created page with "Category:EMA approved in the 2010s")
- 02:52, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2018 (Created page with "Category:EMA approved in the 2010s")
- 02:37, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2017 (Created page with "Category:EMA approved in the 2010s")
- 02:35, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2016 (Created page with "Category:EMA approved in the 2010s")
- 02:00, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2014 (Created page with "Category:EMA approved in the 2010s")
- 01:44, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2013 (Created page with "Category:EMA approved in the 2010s")
- 00:49, 5 December 2021 Jwarner talk contribs created page Category:EMA approved in 2012 (Created page with "Category:EMA approved in the 2010s")
- 16:37, 4 December 2021 Jwarner talk contribs created page Category:EMA approved in 2011 (Created page with "Category:EMA approved in the 2010s")
- 14:54, 4 December 2021 Jwarner talk contribs created page Category:EMA approved in 2010 (Created page with "Category:EMA approved in the 2010s")
- 14:48, 4 December 2021 Jwarner talk contribs created page Category:EMA approved in 2009 (Created page with "Category:EMA approved in the 2000s")
- 13:14, 4 December 2021 Jwarner talk contribs created page Category:EMA approved in 2008 (Created page with "Category:EMA approved in the 2000s")
- 13:13, 4 December 2021 Jwarner talk contribs created page Category:EMA approved in 2006 (Created page with "Catgory:EMA approved in the 2000s")
- 13:14, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in 2004 (Created page with "Category:EMA approved in the 2000s")
- 13:01, 3 December 2021 Jwarner talk contribs created page Category:FDA withdrawn in 2021 (Created page with "Category:Discontinued drugs")
- 13:00, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in 2001 (Created page with "Category:EMA approved in the 2000s")
- 12:55, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in the 2000s (Created page with "Category:EMA approved in the 21st century")
- 12:55, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in 2000 (Created page with "Category:EMA approved in the 2000s")
- 12:51, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in the 21st century (Created page with "Category:EMA approved drugs")
- 12:51, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in the 2010s (Created page with "Category:EMA approved in the 21st century")
- 12:50, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in 2015 (Created page with "Category:EMA approved in the 2010s")
- 12:49, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in the 20th century (Created page with "Category:EMA approved drugs")
- 12:49, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in the 1990s (Created page with "Category:EMA approved in the 20th century")
- 12:48, 3 December 2021 Jwarner talk contribs created page Category:EMA approved in 1995 (Created page with "Category:FDA approved in the 1990s")
- 03:07, 29 November 2021 Jwarner talk contribs created page Light-chain (AL) amyloidosis - null regimens (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 03:06, 29 November 2021 Jwarner talk contribs created page Light-chain (AL) amyloidosis - historical (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 03:03, 28 November 2021 Jwarner talk contribs created page Osteosarcoma - historical (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 01:36, 12 November 2021 Jwarner talk contribs created page Filgrastim-aafi (Nivestym) (Created page with "==General information== Class/mechanism: Recombinant human granulocyte colony-stimulating factor (G-CSF). Binds to cell surface receptors on hematopoietic cells and stimulate...")
- 01:30, 12 November 2021 Jwarner talk contribs created page Pegfilgrastim-apgf (Nyvepria) (Created page with "==General information== Class/mechanism: Recombinant human granulocyte colony-stimulating factor (G-CSF), biosimilar of pegfilgrastim. Binds to cell surface receptors on hemat...")
- 01:27, 12 November 2021 Jwarner talk contribs created page Rituximab-arrx (Riabni) (Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Rituximab (Rituxan) page, except for the details of FDA indication.''' ==General...")
- 22:40, 6 November 2021 Jwarner talk contribs created page Category:Desmoid tumor regimens (Created page with "Category:Soft tissue sarcoma regimens")
- 22:39, 6 November 2021 Jwarner talk contribs created page Category:Desmoid tumor medications (Created page with "Category:Soft tissue sarcoma medications")
- 22:36, 6 November 2021 Jwarner talk contribs created page Desmoid tumors (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 16:19, 5 November 2021 Jwarner talk contribs created page File:AK.JPG
- 16:19, 5 November 2021 Jwarner talk contribs uploaded File:AK.JPG
- 14:10, 4 November 2021 Jwarner talk contribs created page Category:Non-Hodgkin lymphoma regimens (Created page with "Category:Lymphoma regimens")
- 14:02, 4 November 2021 Jwarner talk contribs created page Non-Hodgkin lymphoma, pediatric (Created page with "{{#lst:Section editor transclusions|peds}} <big>''This page contains studies that were specific to pediatric populations, who are generally treated based on risk-stratificatio...")
- 21:42, 29 October 2021 Jwarner talk contribs moved page Asciminib (ABL001) to Asciminib (Scemblix) (FDA approval)
- 12:12, 29 October 2021 Jwarner talk contribs created page Epcoritamab (GEN-3013) (Created page with "==General information== Class/mechanism from the NCI Drug Dictionary: A bispecific monoclonal antibody, with potential immunomodulating and antineoplastic activities. Epcorita...")
- 18:50, 16 October 2021 Jwarner talk contribs created page Lutetium-177-PSMA-617 (Created page with "==Preliminary data== #'''VISION:''' Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, Tagawa ST, Nordquist LT, Vaishampayan N, El-Haddad G, Park CH, Beer TM, Armour...")
- 18:41, 21 September 2021 Jwarner talk contribs created page Category:Anti-TF antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 18:40, 21 September 2021 Jwarner talk contribs created page Tisotumab vedotin (Tivdak) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: An antibody-drug conjugate (ADC) comprised of a monoclonal antibody against human tissue factor (TF) covalently coupled,...")
- 18:12, 21 September 2021 Jwarner talk contribs created page Category:Differentiated thyroid cancer medications (Created page with "Category:Thyroid cancer medications")
- 18:10, 21 September 2021 Jwarner talk contribs created page Category:Medullary thyroid cancer medications (Created page with "Category:Thyroid cancer medications")
- 18:07, 21 September 2021 Jwarner talk contribs created page Medullary thyroid cancer (Created page with "Note: these are regimens tested in histology-specific populations, please see the '''main thyroid cancer page''' for other regimens. {| class="wikitable" st...")
- 18:06, 21 September 2021 Jwarner talk contribs created page Differentiated thyroid cancer (Created page with "Note: these are regimens tested in histology-specific populations, please see the '''main thyroid cancer page''' for other regimens. {| class="wikitable" st...")
- 12:41, 18 September 2021 Jwarner talk contribs created page Mobocertinib (Exkivity) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: An orally available inhibitor of human epidermal growth factor receptor (EGFR) exon 20 insertion mutations, with antineop...")
- 01:44, 2 June 2021 Jwarner talk contribs moved page Infigratinib (BGJ398) to Infigratinib (Truseltiq) (FDA approval with new brand name)
- 15:17, 1 June 2021 Jwarner talk contribs moved page Sotorasib (AMG 510) to Sotorasib (Lumakras) (FDA approval)
- 20:10, 27 May 2021 Jwarner talk contribs uploaded File:Arnason.jpg (Jon Arnason MD)
- 12:05, 27 May 2021 Jwarner talk contribs moved page Naxitamab-gqgk (Danyelza) to Naxitamab (Danyelza) (Following convention to drop the four-letter suffix from main names)
- 00:13, 22 May 2021 Jwarner talk contribs moved page Adenocarcinoma of unknown primary to Carcinoma of unknown primary (consolidation)
- 01:18, 20 May 2021 Jwarner talk contribs moved page Category:T-cel leukemia medications to Category:T-cell leukemia medications
- 16:12, 9 May 2021 Jwarner talk contribs moved page Azacitidine (Onureg) to Azacitidine oral (Onureg) (Disambiguation)
- 18:12, 3 April 2021 Jwarner talk contribs moved page Tositumomab & I-131 (Bexxar) to Tositumomab and I-131 (Bexxar) (Removing special character)
- 00:29, 30 March 2021 Jwarner talk contribs moved page Bb2121 to Idecabtagene vicleucel (Abecma) (FDA approval with new brand name)
- 13:16, 13 March 2021 Jwarner talk contribs moved page Category:Radioimmunotherapeutic to Category:Radioimmunoconjugate
- 16:07, 24 February 2021 Jwarner talk contribs moved page Breast cancer, ER/HER2 co-expressing to Breast cancer, ER & HER2 co-expressing (Protected character)
- 00:47, 17 February 2021 Jwarner talk contribs moved page Tivozanib (AV-951) to Tivozanib (Fotivda) (EMA approval with brand name)
- 13:42, 6 February 2021 Jwarner talk contribs moved page Umbralisib (TGR-1202) to Umbralisib (Ukoniq) (FDA approval with new brand name)
- 02:08, 6 February 2021 Jwarner talk contribs moved page Lisocabtagene maraleucel (Liso-cel) to Lisocabtagene maraleucel (Breyanzi) (FDA approval with new brand name)
- 20:28, 3 February 2021 Jwarner talk contribs moved page Tepotinib (EMD-1214063) to Tepotinib (Tepmetko) (FDA approval with new brand name)
- 18:08, 24 January 2021 Jwarner talk contribs moved page Colon cancer, KRAS wild-type to Colon cancer, RAS wild-type (Generalizing beyond KRAS)
- 18:30, 18 December 2020 Jwarner talk contribs moved page Relugolix (Relumina) to Relugolix (Orgovyx) (FDA approval with new brand name)
- 13:53, 16 December 2020 Jwarner talk contribs moved page Heptaplatin (Sunpla) to Heptaplatin (SunPla)
- 17:48, 9 December 2020 Jwarner talk contribs moved page Carmustine wafer, polifeprosan 20 (Gliadel) to Carmustine wafer, polifeprosan 20 (Gliadel wafer)
- 13:50, 24 October 2020 Jwarner talk contribs moved page Example orders for mFOLFOX 6 & Bevacizumab (Avastin) in colon cancer to Example orders for mFOLFOX6-B in colon cancer
- 14:02, 1 September 2020 Jwarner talk contribs uploaded File:GauravGoyal.jpg
- 13:39, 1 September 2020 Jwarner talk contribs uploaded File:LauraGraham.jpg
- 13:36, 1 September 2020 Jwarner talk contribs uploaded File:RisaWong.jpg
- 22:23, 3 August 2020 Jwarner talk contribs moved page MOR208 to Tafasitamab (Monjuvi) (FDA approval)
- 23:55, 24 April 2020 Jwarner talk contribs moved page Sacituzumab govitecan (IMMU-132) to Sacituzumab govitecan (Trodelvy) (FDA approval)
- 14:47, 18 April 2020 Jwarner talk contribs moved page Tucatinib (ARRY-380) to Tucatinib (Tukysa) (FDA approval)
- 23:56, 10 April 2020 Jwarner talk contribs moved page Selumetinib (AZD6244) to Selumetinib (Koselugo) (FDA approval)
- 18:09, 17 March 2020 Jwarner talk contribs uploaded File:Coronavirus-cdcc.jpg
- 01:06, 3 March 2020 Jwarner talk contribs moved page Isatuximab (SAR-650984) to Isatuximab (Sarclisa) (FDA approval)
- 15:16, 23 January 2020 Jwarner talk contribs moved page Category:Kaposi's sarcoma regimens to Category:Kaposi sarcoma regimens
- 18:31, 10 January 2020 Jwarner talk contribs moved page Vocabulary relationships to HemOnc vocabulary relationships
- 18:31, 10 January 2020 Jwarner talk contribs moved page Vocabulary concepts to HemOnc vocabulary concepts
- 22:00, 21 November 2019 Jwarner talk contribs moved page Crizanlizumab (SEG101) to Crizanlizumab (Adakveo) (FDA approval)
- 12:43, 7 November 2019 Jwarner talk contribs uploaded File:RyanNguyen.jpg (Dr. Ryan Nguyen)
- 22:15, 13 October 2019 Jwarner talk contribs uploaded a new version of File:Bishal gyawali.jpg
- 22:13, 13 October 2019 Jwarner talk contribs uploaded File:Bishal gyawali.jpg
- 19:48, 2 October 2019 Jwarner talk contribs uploaded File:Eric Marks Headshot.jpg
- 14:13, 1 October 2019 Jwarner talk contribs moved page Category:Autoimmune hemolytic anemia regimens to Category:Warm autoimmune hemolytic anemia regimens
- 14:04, 1 October 2019 Jwarner talk contribs moved page Autoimmune hemolytic anemia to Warm autoimmune hemolytic anemia (More accurate)
- 20:27, 6 September 2019 Jwarner talk contribs moved page Nintedanib (BIBF 1120) to Nintedanib (Vargatef)
- 15:50, 19 August 2019 Jwarner talk contribs moved page Entrectinib (RXDX-101) to Entrectinib (Rozlytrek) (FDA approval)
- 14:20, 6 August 2019 Jwarner talk contribs moved page Lobaplatin to Lobaplatin (D-19466)
- 17:45, 5 August 2019 Jwarner talk contribs moved page Epratuzumab (humanised anti-CD22 antibody) to Epratuzumab (LymphoCide) (brand name available)
- 17:01, 31 July 2019 Jwarner talk contribs moved page Darolutamide (ODM-201) to Darolutamide (Nubeqa) (FDA approval)
- 18:12, 3 July 2019 Jwarner talk contribs moved page Selinexor (KPT-330) to Selinexor (Xpovio) (FDA approval)
- 23:25, 23 June 2019 Jwarner talk contribs uploaded File:NShah.png
- 01:58, 20 June 2019 Jwarner talk contribs moved page AZD5363 to Capivasertib (AZD5363)
- 17:31, 27 February 2019 Jwarner talk contribs uploaded File:Social-twitter-icon.png (Twitter icon)
- 20:20, 7 February 2019 Jwarner talk contribs moved page Heparin to Unfractionated heparin (UFH) (Concept refinement)
- 19:17, 6 February 2019 Jwarner talk contribs moved page Caplacizumab (ALX-0081) to Caplacizumab (Cablivi) (FDA approval)
- 17:48, 9 January 2019 Jwarner talk contribs uploaded File:Chowdhery.jpg (Rozina Chowdhery MD)
- 15:50, 9 January 2019 Jwarner talk contribs uploaded File:Seifter.jpg (Ari Seifter MD)
- 14:35, 9 January 2019 Jwarner talk contribs uploaded File:C Schwartz.jpg (Candice Schwartz MD)
- 19:05, 18 December 2018 Jwarner talk contribs moved page SL-401 to Tagraxofusp (Elzonris) (Generic name available)
- 19:02, 18 December 2018 Jwarner talk contribs moved page SGN-CD19A to Denintuzumab mafodotin (SGN-CD19A) (Generic name available)
- 18:57, 18 December 2018 Jwarner talk contribs moved page CC-292 (AVL-292) to Spebrutinib (CC-292) (Generic name available)
- 18:49, 29 November 2018 Jwarner talk contribs moved page Gilteritinib (ASP2215) to Gilteritinib (Xospata) (FDA approval)
- 03:20, 27 November 2018 Jwarner talk contribs moved page Larotrectinib (LOXO-101) to Larotrectinib (Vitrakvi) (FDA approval)
- 02:26, 5 November 2018 Jwarner talk contribs moved page Lorlatinib (PF-06463922) to Lorlatinib (Lorbrena) (FDA approval)
- 00:18, 2 November 2018 Jwarner talk contribs uploaded File:Release notes 2018-10-29.docx
- 16:41, 10 October 2018 Jwarner talk contribs moved page Uterine cancer to Endometrial cancer (More common naming convention)
- 02:38, 10 October 2018 Jwarner talk contribs moved page Category:Nonsteroidal androgen receptor inhibitors to Category:Nonsteroidal antiandrogens
- 19:25, 4 October 2018 Jwarner talk contribs moved page Emicizumab-kxwh (Hemlibra) to Emicizumab (Hemlibra)
- 15:39, 2 October 2018 Jwarner talk contribs moved page Cemiplimab (REGN2810) to Cemiplimab (Libtayo) (FDA approval)
- 23:34, 27 September 2018 Jwarner talk contribs moved page Dacomitinib (PF-00299804) to Dacomitinib (Vizimpro) (FDA approval)
- 01:25, 27 September 2018 Jwarner talk contribs moved page Duvelisib (IPI-145) to Duvelisib (Copiktra) (FDA approval)
- 19:13, 13 September 2018 Jwarner talk contribs moved page Moxetumomab pasudotox (HA22) to Moxetumomab pasudotox (Lumoxiti) (FDA approval)
- 17:19, 7 September 2018 Jwarner talk contribs uploaded File:Release notes 2018-08-25.docx (Ontology version 2018-08-25 release notes)
- 20:39, 28 August 2018 Jwarner talk contribs uploaded File:Release notes 2018-08-17.docx (Ontology version 2018-08-17 release notes)
- 12:02, 23 August 2018 Jwarner talk contribs moved page Von Willebrand Factor and factor VIII complex, human to Von Willebrand factor and factor VIII complex, human (Naming convention)
- 02:27, 12 August 2018 Jwarner talk contribs moved page Mepolizumab (Bosatria) to Mepolizumab (Nucala) (FDA approval under a different brand name)
- 17:54, 10 August 2018 Jwarner talk contribs moved page Mogamulizumab (KW-0761) to Mogamulizumab (Poteligeo) (FDA approval)
- 18:29, 7 August 2018 Jwarner talk contribs moved page Basal cell carcinoma (BCC) to Cutaneous basal cell carcinoma
- 18:24, 7 August 2018 Jwarner talk contribs moved page Squamous cell carcinoma (SCC) to Cutaneous squamous cell carcinoma
- 17:50, 30 July 2018 Jwarner talk contribs moved page Epinephrine (Epipen) to Epinephrine autoinjector (Epipen)
- 22:17, 20 July 2018 Jwarner talk contribs moved page Ivosidenib (AG-120) to Ivosidenib (Tibsovo) (FDA approval)
- 22:04, 20 July 2018 Jwarner talk contribs moved page Ticlodipine (Ticlid) to Ticlopidine (Ticlid) (typo)
- 23:50, 27 June 2018 Jwarner talk contribs moved page Binimetinib (MEK162) to Binimetinib (Mektovi) (FDA approval)
- 23:45, 27 June 2018 Jwarner talk contribs moved page Encorafenib (LGX818) to Encorafenib (Braftovi) (FDA approval)
- 02:57, 7 June 2018 Jwarner talk contribs moved page Test: Jane Doe to Academic Medicine wiki-based narrative
- 01:09, 24 May 2018 Jwarner talk contribs uploaded File:Release notes 2018-05-08.docx (HemOnc.org ontology version 2018-05-08 release notes.)
- 18:38, 21 May 2018 Jwarner talk contribs moved page Avatrombopag (E5501) to Avatrombopag (Doptelet) (FDA approval)
- 18:36, 11 May 2018 Jwarner talk contribs moved page AG-120 to Ivosidenib (AG-120) (generic name available)
- 17:51, 4 May 2018 Jwarner talk contribs moved page Andexanet alfa (PRT4445) to Factor Xa, recombinant, inactivated-zhzo (Andexxa) (FDA approval)
- 23:19, 4 March 2018 Jwarner talk contribs uploaded File:Naina Singh.JPG (Naina Singh headshot)
- 03:05, 25 February 2018 Jwarner talk contribs moved page Apatinib (YN968D1) to Apatinib (Aitan) (brand name added)
- 01:50, 19 February 2018 Jwarner talk contribs moved page Apalutamide (ARN-509) to Apalutamide (Erleada) (FDA approval)
- 17:43, 5 December 2017 Jwarner talk contribs moved page Category:Venous thromboembolism regimens to Category:Venous thromboembolism (VTE) regimens
- 23:50, 2 December 2017 Jwarner talk contribs moved page Granisetron (Kytril) to Granisetron (Multiple brand names)
- 15:58, 2 December 2017 Jwarner talk contribs moved page Prothrombin Complex Concentrate, Human (Kcentra) to Prothrombin Complex Concentrate, human (To accommodate multiple brand names)
- 20:55, 27 November 2017 Jwarner talk contribs moved page Cytomegalovirus (CMV) Human Immunoglobulin (Cytogam) to Cytomegalovirus Immune Globulin (Cytogam) (Consistency)
- 20:52, 27 November 2017 Jwarner talk contribs moved page Actinium-225 (225Ac)-Lintuzumab (Actimab-A) to Actinium Ac 225 lintuzumab (Actimab-A) (Consistent format with NCI)
- 00:16, 19 November 2017 Jwarner talk contribs moved page Entinostat to Entinostat (SNDX-275)
- 16:50, 18 November 2017 Jwarner talk contribs moved page Caplacizumab to Caplacizumab (ALX-0081)
- 19:37, 6 November 2017 Jwarner talk contribs moved page Category:Immunosuppresants to Category:Immunosuppressants (Misspelled!)
- 17:12, 3 November 2017 Jwarner talk contribs moved page Tegafur, gimeracil, oteracil (Teysuno, S-1) to Tegafur, gimeracil, oteracil (S-1) (simplification)
- 14:08, 1 November 2017 Jwarner talk contribs moved page Acalabrutinib (ACP-196) to Acalabrutinib (Calquence) (FDA approval)
- 15:13, 29 October 2017 Jwarner talk contribs moved page Aclarubicin (Aclacinomycin) to Aclarubicin (Aclacinon) (Correct brand name)
- 00:13, 27 October 2017 Jwarner talk contribs moved page Afatinib (Gliotrif) to Afatinib (Gilotrif) (Misspelled!)
- 02:36, 24 October 2017 Jwarner talk contribs moved page Sarcoma to Soft tissue sarcoma (Naming convention)
- 02:29, 24 October 2017 Jwarner talk contribs moved page Bone cancer to Bone sarcoma (Naming convention)
- 16:28, 19 October 2017 Jwarner talk contribs moved page Axicabtagene ciloleucel (KTE-C19) to Axicabtagene ciloleucel (Yescarta) (FDA approval)
- 13:15, 14 October 2017 Jwarner talk contribs moved page Category:GIST regimens to Category:Gastrointestinal stromal tumor regimens (Consistency)
- 13:15, 14 October 2017 Jwarner talk contribs moved page Category:GIST regimens to Category:Gastrointestinal stromal tumor (Consistency)
- 02:41, 14 October 2017 Jwarner talk contribs moved page Histiocytoses to Erdheim-Chester disease (Disambiguation)
- 02:59, 5 October 2017 Jwarner talk contribs uploaded File:Sanjay mohan.png (Headshot)
- 02:56, 5 October 2017 Jwarner talk contribs uploaded File:Tillman Benjamin-2.jpg (Headshot)
- 02:55, 5 October 2017 Jwarner talk contribs uploaded File:Nkv.jpg (Headshot)
- 02:55, 5 October 2017 Jwarner talk contribs uploaded File:Jim chen.jpeg (Headshot)
- 02:54, 5 October 2017 Jwarner talk contribs uploaded File:Aymen elfiky.jpg (Headshot)
- 02:42, 5 October 2017 Jwarner talk contribs uploaded File:Shruti.jpg (Headshot)
- 02:15, 4 October 2017 Jwarner talk contribs uploaded File:Arichall 400x400.jpg (Aric Hall headshot)
- 19:48, 28 September 2017 Jwarner talk contribs moved page Abemaciclib (LY2835219) to Abemaciclib (Verzenio) (FDA approval)
- 19:44, 15 September 2017 Jwarner talk contribs moved page Category:Nitrosureas to Category:Nitrosoureas (Misspelled!)
- 18:35, 14 September 2017 Jwarner talk contribs moved page Copanlisib (BAY 80-6946) to Copanlisib (Aliqopa) (FDA approval)
- 18:11, 11 September 2017 Jwarner talk contribs uploaded File:Warner Jeremy2 compact.jpg
- 21:14, 25 August 2017 Jwarner talk contribs moved page Rituximab and hyaluronidase human (Rituximab Hycela) to Rituximab and hyaluronidase human (Rituxan Hycela) (Clarified brand name)
- 21:11, 25 August 2017 Jwarner talk contribs moved page Protamine sulfate to Protamine sulfate (USP) (RxNorm matching)
- 17:52, 17 August 2017 Jwarner talk contribs moved page Inotuzumab ozogamicin (CMC-544) to Inotuzumab ozogamicin (Besponsa) (FDA approval)
- 22:03, 16 August 2017 Jwarner talk contribs moved page GDC-0941 to Pictilisib (GDC-0941) (Generic name available)
- 19:04, 10 August 2017 Jwarner talk contribs moved page Cytarabine and daunorubicin (Vyxeos) to Cytarabine and daunorubicin liposomal (Vyxeos)
- 02:06, 5 August 2017 Jwarner talk contribs moved page Category:Mutation-specific drugs to Category:Mutation-specific medications
- 16:14, 2 August 2017 Jwarner talk contribs moved page Tegafur-uracil (UFT) to Tegafur and uracil (UFT)
- 14:53, 2 August 2017 Jwarner talk contribs moved page Category:Fluoropyrimidine to Category:Fluoropyrimidines
- 13:28, 2 August 2017 Jwarner talk contribs moved page AG-221 to Enasidenib (Idhifa) (FDA approval)
- 03:09, 23 July 2017 Jwarner talk contribs moved page Category:Anti-CD37 medications to Category:Anti-CD37 antibodies
- 21:15, 17 July 2017 Jwarner talk contribs moved page Neratinib (HKI-272) to Neratinib (Nerlynx) (FDA approval)
- 15:09, 12 July 2017 Jwarner talk contribs moved page CPX-351 to Cytarabine and daunorubicin (Vyxeos)
- 19:35, 16 June 2017 Jwarner talk contribs moved page Castleman’s disease to Castleman disease (More consistent with modern nomenclature)
- 13:51, 12 June 2017 Jwarner talk contribs moved page XmAb5574 (MOR00208) to MOR208
- 19:47, 1 May 2017 Jwarner talk contribs moved page Durvalumab (MEDI4736) to Durvalumab (Imfinzi)
- 04:04, 28 March 2017 Jwarner talk contribs moved page Niraparib (MK4827) to Niraparib (Zejula)
- 02:51, 23 January 2017 Jwarner talk contribs moved page T-cell acute lymphocytic leukemia to T-cell acute lymphoblastic leukemia (Conforms to WHO terminology)
- 02:48, 23 January 2017 Jwarner talk contribs moved page Acute lymphocytic leukemia to B-cell acute lymphoblastic leukemia (Conforms to WHO terminology)
- 04:43, 28 September 2016 Jwarner talk contribs moved page Epoetin alfa (Procrit) to Erythropoietin
- 01:29, 15 September 2016 Jwarner talk contribs moved page Mast cell diseases to Systemic mastocytosis
- 20:43, 18 May 2016 Jwarner talk contribs moved page Atezolizumab (MPDL3280A) to Atezolizumab (Tecentriq) (FDA approval)
- 14:41, 15 April 2016 Jwarner talk contribs moved page Bendamustine (Bendeka) to Bendamustine (Confusion over brand name)
- 17:48, 11 April 2016 Jwarner talk contribs moved page Venetoclax (ABT-199) to Venetoclax (Venclexta)
- 18:35, 2 April 2016 Jwarner talk contribs moved page Tosedostat to Tosedostat (CHR-2797) (code name added)
- 01:43, 28 January 2016 Jwarner talk contribs uploaded File:P values xkcd.png
- 19:40, 18 December 2015 Jwarner talk contribs moved page Radium Ra 223 (Xofigo) to Radium-223 (Xofigo)
- 01:55, 1 December 2015 Jwarner talk contribs moved page Elotuzumab (HuLuc63) to Elotuzumab (Empliciti) (FDA approval)
- 01:27, 21 November 2015 Jwarner talk contribs moved page Ixazomib (MLN9708) to Ixazomib (Ninlaro)
- 22:25, 22 October 2015 Jwarner talk contribs moved page Irinotecan nanoliposomal (PEP02, MM-398) to Irinotecan liposome (Onivyde) (FDA approval)
- 18:41, 6 September 2015 Jwarner talk contribs moved page Hypereosinophilic syndrome (HES) to Hypereosinophilic syndrome
- 16:12, 25 May 2015 Jwarner talk contribs moved page Afuresertib to Afuresertib (GSK2110183)
- 00:22, 13 May 2015 Jwarner talk contribs moved page Hemophagocytic lymphohistiocytosis (HLH) to Hemophagocytic lymphohistiocytosis
- 17:44, 10 May 2015 Jwarner talk contribs moved page Pacritinib to Pacritinib (SB1518)
- 17:07, 4 March 2015 Jwarner talk contribs uploaded File:Efficacy.jpg (P-values in plain English. License to reproduce on HemOnc.org obtained from Elsevier on March 3rd, 2015. Reprinted from The Lancet, Vol. 373 number 9679, Stuart J Pocock, James H Ware, Translating statistical findings into plain English, 1926-8, Copyri...)
- 16:16, 1 February 2015 Jwarner talk contribs moved page Hematology/Oncology & allied organizations to Professional organizations
- 03:28, 6 January 2015 Jwarner talk contribs moved page IPI-145 to Duvelisib (IPI-145)
- 02:27, 20 December 2014 Jwarner talk contribs moved page IPH 2101 (Anti-KIR) to IPH 2101
- 02:24, 20 December 2014 Jwarner talk contribs moved page DN24-02 to Lapuleucel-T (DN24-02)
- 02:22, 20 December 2014 Jwarner talk contribs moved page CAT-3888 (BL22) to BL22 immunotoxin (CAT-3888)
- 02:20, 20 December 2014 Jwarner talk contribs moved page BHQ880 (Anti-DKK1 Antibody) to BHQ880
- 21:30, 19 December 2014 Jwarner talk contribs moved page Olaparib (AZD-2281) to Olaparib (Lynparza) (FDA approval)
- 02:32, 9 December 2014 Jwarner talk contribs moved page ABT-199 (GDC-0199) to Venetoclax (ABT-199)
- 05:42, 4 December 2014 Jwarner talk contribs moved page Blinatumomab (AMG 103) to Blinatumomab (Blincyto) (FDA approval)
- 14:14, 26 November 2014 Jwarner talk contribs moved page Momelotinib to Momelotinib (CYT387)
- 04:55, 23 November 2014 Jwarner talk contribs moved page SAR3419 to Coltuximab ravtansine (CoR, SAR3419)
- 04:52, 23 November 2014 Jwarner talk contribs moved page Imetelstat to Imetelstat (GRN163L)
- 02:54, 16 November 2014 Jwarner talk contribs moved page Radotinib (IY5511HCL) to Radotinib (Supect)
- 20:31, 13 November 2014 Jwarner talk contribs moved page Fosaprepitant (Emend) to Fosaprepitant (Emend for Injection) over redirect (Corrected the brand name)
- 19:40, 12 November 2014 Jwarner talk contribs moved page Forodesine to Forodesine (Fodosine) (Added brand name.)
- 15:04, 3 November 2014 Jwarner talk contribs moved page Argatroban to Argatroban (Acova) (Consistency with other HemOnc.org drug pages.)
- 20:53, 8 May 2012 User account Jwarner talk contribs was created